PolyTherics Ltd has become the latest company to announce a collaboration in the antibody-drug conjugate field – a technology that is attracting growing numbers of companies that are developing treatments for cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
